Innovative Technology Focus Just Biotherapeutics specializes in cutting-edge biotherapeutic development from molecule design to manufacturing, providing a comprehensive technological edge that appeals to pharmaceutical companies seeking advanced biologics solutions.

Strategic Industry Partnerships Recent collaborations with major players like Teva Pharmaceutical indicate strong industry recognition, suggesting opportunities to expand partnerships with other global biopharma companies looking to optimize biologic development and manufacturing.

Robust Funding & Growth With over 71 million dollars in funding and acquisitions by companies such as Evotec, Just demonstrates a solid financial foundation and growth trajectory, making it an attractive partner for organizations investing in innovative biologics research.

Specialized Expertise Targeting the biologics development niche, Just’s unique position appeals to companies aiming to streamline their molecule-to-manufacturing pipeline, opening sales opportunities for advanced bioprocessing technologies and consultancy services.

Technology Stack & Innovation Utilizing advanced tools like TensorFlow, AWS, and custom software, Just emphasizes innovation, presenting prospects for technology providers and integrators to offer supporting solutions that enhance their research and development capabilities.